Sign In
NASDAQ:BLUE
bluebird bio Stock Earnings Reports
$3.90
-0.0600 (-1.52%)
At Close: Mar 21, 2025
bluebird bio Earnings Calls
Q4 2024
(Upcoming)
| Release date | Mar 24, 2025 |
| EPS estimate | -$6.30 |
| EPS actual | - |
| Revenue estimate | 27.072M |
| Revenue actual | - |
| Expected change | +/- 13.00% |
Q3 2024
Beat
-$6.20 (14.84%)
| Release date | Nov 14, 2024 |
| EPS estimate | -$7.28 |
| EPS actual | -$6.20 |
| EPS Surprise | 14.84% |
| Revenue estimate | 18.051M |
| Revenue actual | 10.612M |
| Revenue Surprise | -41.21% |
Q2 2024
Missed
-$15.60 (-3,800.00%)
| Release date | Sep 13, 2024 |
| EPS estimate | -$0.400 |
| EPS actual | -$15.60 |
| EPS Surprise | -3,800.00% |
| Revenue estimate | 10.66M |
| Revenue actual | 16.101M |
| Revenue Surprise | 51.04% |
Q1 2024
Beat
$0.210 (142.86%)
| Release date | May 09, 2024 |
| EPS estimate | -$0.490 |
| EPS actual | $0.210 |
| EPS Surprise | 142.86% |
| Revenue estimate | 10.16M |
| Revenue actual | 18.573M |
| Revenue Surprise | 82.81% |
Last 4 Quarters for bluebird bio
Below you can see how BLUE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Q1 2024
Beat
| Release date | May 09, 2024 |
| Fiscal end date | Mar 31, 2024 |
| Price on release | $22.40 |
| EPS estimate | -$0.490 |
| EPS actual | $0.210 |
| EPS surprise | 142.86% |
| Date | Price |
|---|---|
| May 03, 2024 | $18.00 |
| May 06, 2024 | $20.00 |
| May 07, 2024 | $20.20 |
| May 08, 2024 | $19.49 |
| May 09, 2024 | $22.40 |
| May 10, 2024 | $21.20 |
| May 13, 2024 | $20.40 |
| May 14, 2024 | $21.40 |
| May 15, 2024 | $21.40 |
| 4 days before | 24.44% |
| 4 days after | -4.46% |
| On release day | -5.36% |
| Change in period | 18.89% |
Q2 2024
Missed
| Release date | Sep 13, 2024 |
| Fiscal end date | Jun 30, 2024 |
| Price on release | $12.12 |
| EPS estimate | -$0.400 |
| EPS actual | -$15.60 |
| EPS surprise | -3,800.00% |
| Date | Price |
|---|---|
| Sep 09, 2024 | $10.77 |
| Sep 10, 2024 | $11.41 |
| Sep 11, 2024 | $11.64 |
| Sep 12, 2024 | $11.48 |
| Sep 13, 2024 | $12.12 |
| Sep 16, 2024 | $11.55 |
| Sep 17, 2024 | $10.00 |
| Sep 18, 2024 | $9.90 |
| Sep 19, 2024 | $9.84 |
| 4 days before | 12.53% |
| 4 days after | -18.81% |
| On release day | -4.70% |
| Change in period | -8.64% |
Q3 2024
Beat
| Release date | Nov 14, 2024 |
| Fiscal end date | Sep 30, 2024 |
| Price on release | $7.25 |
| EPS estimate | -$7.28 |
| EPS actual | -$6.20 |
| EPS surprise | 14.84% |
| Date | Price |
|---|---|
| Nov 08, 2024 | $8.11 |
| Nov 11, 2024 | $8.11 |
| Nov 12, 2024 | $7.81 |
| Nov 13, 2024 | $7.53 |
| Nov 14, 2024 | $7.25 |
| Nov 15, 2024 | $6.42 |
| Nov 18, 2024 | $6.66 |
| Nov 19, 2024 | $6.10 |
| Nov 20, 2024 | $6.06 |
| 4 days before | -10.60% |
| 4 days after | -16.41% |
| On release day | -11.45% |
| Change in period | -25.28% |
Q4 2024
(Upcoming)
| Release date | Mar 24, 2025 |
| Fiscal end date | Dec 30, 2024 |
| Price on release | - |
| EPS estimate | -$6.30 |
| EPS actual | - |
| Date | Price |
|---|---|
| Mar 17, 2025 | $3.96 |
| Mar 18, 2025 | $3.94 |
| Mar 19, 2025 | $3.93 |
| Mar 20, 2025 | $3.96 |
| Mar 21, 2025 | $3.90 |
bluebird bio Earnings History
Earnings Calendar
FAQ
When is the earnings report for BLUE?
bluebird bio (BLUE) has scheduled its earnings report for Mar 24, 2025 after the markets close.
What is the BLUE price-to-earnings (P/E) ratio?
BLUE P/E ratio as of Mar 21, 2025 (TTM) is -2.54.
What is the BLUE EPS forecast?
The forecasted EPS (Earnings Per Share) for bluebird bio (BLUE) for the first fiscal quarter 2024 is -$6.30.
What are bluebird bio's retained earnings?
On its balance sheet, bluebird bio reported retained earnings of $10.61 million for the latest quarter ending Sep 30, 2024.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
